IONS Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. (IONS) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 81% planned / 19% discretionary
Largest single sale: $14.9M.
Where they traded
Last open-market purchase: July 31, 2026 , by Hayden Michael R .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Hayden Michael R | Director | Buy | 5,000 | $51.60 | $258.0K | 24,000 | |
| Hayden Michael R | Director | Buy | 15,000 | $53.38 | $800.7K | 19,000 | |
| BENNETT C FRANK 2 fills | EVP, Chief Scientific Officer | Sell 10b5-1 | 20,536 | $84.95 | $1.7M | 75,018 −21.5% of holding | |
| Diaz Allene M. | Director | Sell 10b5-1 | 10,111 | $85.42 | $863.6K | 3,811 −72.6% of holding | |
| Kordasiewicz Holly B. | EVP, Chief Development Officer | Sell 10b5-1 | 362 | $84.30 | $30.5K | 22,096 −1.6% of holding | |
| KLEIN JOSEPH III 2 fills | Director | Sell 10b5-1 | 11,518 | $79.04 | $910.4K | 22,433 −33.9% of holding | |
| Monia Brett P | Chief Executive Officer | Sell 10b5-1 | 50,000 | $80.59 | $4.0M | 245,571 −16.9% of holding | |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell 10b5-1 | 26,000 | $81.05 | $2.1M | 77,114 −25.2% of holding | |
| Baroldi Joseph | EVP, Chief Business Officer | Sell 10b5-1 | 5,635 | $80.16 | $451.7K | 4,669 −54.7% of holding | |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell 10b5-1 | 3,069 | $80.00 | $245.5K | 61,470 −4.8% of holding | |
| Monia Brett P | Chief Executive Officer | Sell 10b5-1 | 21,072 | $78.49 | $1.7M | 245,571 −7.9% of holding | |
| Swayze Eric | EVP Research | Sell 10b5-1 | 10,602 | $79.18 | $839.5K | 21,759 −32.8% of holding | |
| Monia Brett P | Chief Executive Officer | Sell 10b5-1 | 14,565 | $78.41 | $1.1M | 245,571 −5.6% of holding | |
| BERTHELSEN SPENCER R | Director | Sell 10b5-1 | 8,000 | $73.49 | $587.9K | 156,013 −4.9% of holding | |
| Kordasiewicz Holly B. 2 fills | EVP, Chief Development Officer | Sell 10b5-1 | 60,846 | $73.41 | $4.5M | 42,300 −59% of holding | |
| BERTHELSEN SPENCER R | Director | Sell 10b5-1 | 8,000 | $75.67 | $605.4K | 156,013 −4.9% of holding | |
| Monia Brett P | Chief Executive Officer | Sell 10b5-1 | 3,220 | $78.68 | $253.3K | 242,662 −1.3% of holding | |
| Monia Brett P | Chief Executive Officer | Sell 10b5-1 | 1,316 | $78.01 | $102.7K | 242,662 −0.5% of holding | |
| LOSCALZO JOSEPH 2 fills | Director | Sell 10b5-1 | 77,289 | $75.06 | $5.8M | 54,111 −58.8% of holding | |
| KLEIN JOSEPH III 2 fills | Director | Sell 10b5-1 | 10,111 | $73.51 | $743.2K | 12,445 −44.8% of holding | |
| Baroldi Joseph | EVP, Chief Business Officer | Sell 10b5-1 | 1,626 | $71.79 | $116.7K | 44,909 −3.5% of holding | |
| Baroldi Joseph | EVP, Chief Business Officer | Sell | 5,619 | $74.56 | $419.0K | 46,535 −10.8% of holding | |
| Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | Sell | 4,902 | $75.17 | $368.5K | 23,713 −17.1% of holding | |
| Birchler Brian | EVP, Corp and Development Ops | Sell | 973 | $75.04 | $73.0K | 67,500 −1.4% of holding | |
| PARSHALL B LYNNE 2 fills | Director | Sell 10b5-1 | 5,000 | $76.27 | $381.4K | 51,878 −8.8% of holding | |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell 10b5-1 | 6,193 | $74.05 | $458.6K | 16,348 −27.5% of holding | |
| KLEIN JOSEPH III 2 fills | Director | Sell 10b5-1 | 22,321 | $75.55 | $1.7M | 13,230 −62.8% of holding | |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell 10b5-1 | 5,812 | $70.97 | $412.5K | 63,890 −8.3% of holding | |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell 10b5-1 | 10,172 | $73.21 | $744.7K | 82,660 −11% of holding | |
| HOUGEN ELIZABETH L 2 fills | EVP, Finance & CFO | Sell 10b5-1 | 215,048 | $72.40 | $15.6M | 102,272 −67.8% of holding | |
| Jenne Kyle 2 fills | EVP, Chf GL Pdt Str Ofcr | Sell 10b5-1 | 37,277 | $75.85 | $2.8M | 27,800 −57.3% of holding | |
| Monia Brett P 2 fills | Chief Executive Officer | Sell 10b5-1 | 34,103 | $75.92 | $2.6M | 260,253 −11.6% of holding | |
| Monia Brett P 3 fills | Chief Executive Officer | Sell 10b5-1 | 126,670 | $75.20 | $9.5M | 361,950 −25.9% of holding | |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell 10b5-1 | 10,148 | $75.25 | $763.7K | 62,211 −14% of holding | |
| Baroldi Joseph 2 fills | EVP, Chief Business Officer | Sell 10b5-1 | 439 | $80.00 | $35.1K | 4,347 −9.2% of holding | |
| LOSCALZO JOSEPH | Director | Sell 10b5-1 | 200 | $80.00 | $16.0K | 36,330 −0.5% of holding | |
| BENNETT C FRANK 3 fills | EVP, Chief Scientific Officer | Sell 10b5-1 | 85,089 | $79.23 | $6.7M | 94,043 −47.5% of holding | |
| Diaz Allene M. 3 fills | Director | Sell 10b5-1 | 54,878 | $79.35 | $4.4M | 19,424 −73.9% of holding | |
| KLEIN JOSEPH III 3 fills | Director | Sell 10b5-1 | 21,332 | $79.51 | $1.7M | 18,820 −53.1% of holding | |
| Devers Shannon L. 3 fills | EVP, Chief Human Resources Ofc | Sell 10b5-1 | 20,106 | $79.40 | $1.6M | 28,326 −41.5% of holding | |
| Baroldi Joseph 3 fills | EVP, Chief Business Officer | Sell 10b5-1 | 6,220 | $79.72 | $495.9K | 41,317 −13.1% of holding | |
| LOSCALZO JOSEPH | Director | Sell 10b5-1 | 832 | $80.33 | $66.8K | 36,330 −2.2% of holding | |
| Swayze Eric 2 fills | EVP Research | Sell 10b5-1 | 15,642 | $81.76 | $1.3M | 38,312 −29% of holding | |
| PARSHALL B LYNNE | Director | Sell 10b5-1 | 5,000 | $82.72 | $413.6K | 56,344 −8.2% of holding | |
| Monia Brett P | Chief Executive Officer | Sell 10b5-1 | 29,430 | $85.79 | $2.5M | 254,497 −10.4% of holding | |
| BENNETT C FRANK 3 fills | EVP, Chief Scientific Officer | Sell | 85,089 | $82.93 | $7.1M | 80,293 −51.4% of holding | |
| Monia Brett P | Chief Executive Officer | Sell | 62,970 | $82.72 | $5.2M | 283,927 −18.2% of holding | |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell | 6,988 | $83.24 | $581.7K | 132,881 −5% of holding | |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 6,179 | $83.53 | $516.2K | 71,983 −7.9% of holding | |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | 6,179 | $83.45 | $515.6K | 69,702 −8.1% of holding | |
| Birchler Brian | EVP, Corp and Development Ops | Sell | 6,179 | $83.03 | $513.0K | 66,247 −8.5% of holding | |
| Swayze Eric | EVP Research | Sell | 6,179 | $82.93 | $512.4K | 47,747 −11.5% of holding | |
| BENNETT C FRANK | EVP, Chief Scientific Officer | Sell | 5,885 | $82.95 | $488.1K | 100,293 −5.5% of holding | |
| Baroldi Joseph | EVP, Chief Business Officer | Sell | 5,296 | $82.96 | $439.4K | 45,413 −10.4% of holding | |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell 10b5-1 | 3,977 | $81.34 | $323.5K | 22,541 −15% of holding | |
| Monia Brett P | Chief Executive Officer | Sell | 44,034 | $74.82 | $3.3M | 224,683 −16.4% of holding | |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell | 12,922 | $75.22 | $972.0K | 126,307 −9.3% of holding | |
| Swayze Eric 2 fills | EVP Research | Sell | 9,933 | $75.34 | $748.4K | 41,935 −19.2% of holding | |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | 9,302 | $75.59 | $703.1K | 63,890 −12.7% of holding | |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 9,191 | $75.84 | $697.0K | 66,171 −12.2% of holding | |
| BENNETT C FRANK | EVP, Chief Scientific Officer | Sell | 8,977 | $75.15 | $674.6K | 94,757 −8.7% of holding | |
| Birchler Brian | EVP, Corp and Development Ops | Sell | 8,480 | $75.11 | $636.9K | 60,435 −12.3% of holding | |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell | 8,353 | $75.95 | $634.4K | 26,518 −24% of holding | |
| Baroldi Joseph 2 fills | EVP, Chief Business Officer | Sell | 8,056 | $75.75 | $610.3K | 40,431 −16.6% of holding | |
| Kordasiewicz Holly B. | EVP, Chief Development Officer | Sell | 4,141 | $75.66 | $313.3K | 14,718 −22% of holding | |
| Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | Sell | 1,823 | $75.96 | $138.5K | 16,389 −10% of holding | |
| Devers Shannon L. 5 fills | EVP, Chief Human Resources Ofc | Sell 10b5-1 | 44,199 | $85.08 | $3.8M | 17,494 −71.6% of holding | |
| Swayze Eric 2 fills | EVP Research | Sell 10b5-1 | 23,463 | $79.12 | $1.9M | 30,453 −43.5% of holding | |
| WENDER JOSEPH H 2 fills | Director | Sell 10b5-1 | 28,000 | $80.82 | $2.3M | 43,464 −39.2% of holding | |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell 10b5-1 | 16,777 | $80.91 | $1.4M | 17,494 −49% of holding | |
| KLEIN JOSEPH III 3 fills | Director | Sell 10b5-1 | 12,000 | $80.00 | $960.0K | None left | |
| HERMAN JOAN E 2 fills | Director | Sell | 44,000 | $72.13 | $3.2M | 46,086 −48.8% of holding | |
| Geary Richard S 2 fills | EVP, Chief Development Officer | Sell 10b5-1 | 33,038 | $75.72 | $2.5M | 59,657 −35.6% of holding | |
| Birchler Brian | EVP, Corp and Development Ops | Sell 10b5-1 | 8,000 | $76.17 | $609.4K | 48,826 −14.1% of holding | |
| Geary Richard S 2 fills | EVP, Chief Development Officer | Sell 10b5-1 | 1,601 | $75.01 | $120.1K | 59,657 −2.6% of holding | |
| Geary Richard S 2 fills | EVP, Chief Development Officer | Sell | 1,680 | $75.05 | $126.1K | 59,657 −2.7% of holding | |
| Geary Richard S 2 fills | EVP, Chief Development Officer | Sell 10b5-1 | 1,680 | $75.05 | $126.1K | 59,657 −2.7% of holding | |
| Geary Richard S 3 fills | EVP, Chief Development Officer | Sell 10b5-1 | 89,249 | $75.11 | $6.7M | 79,657 −52.8% of holding | |
| LOSCALZO JOSEPH | Director | Sell 10b5-1 | 16,000 | $75.10 | $1.2M | 36,330 −30.6% of holding | |
| WENDER JOSEPH H | Director | Sell 10b5-1 | 11,200 | $75.16 | $841.8K | 64,035 −14.9% of holding | |
| WENDER JOSEPH H 3 fills | Director | Sell 10b5-1 | 16,800 | $73.26 | $1.2M | 89,551 −15.8% of holding | |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell | 1,263 | $73.62 | $93.0K | 17,494 −6.7% of holding | |
| Swayze Eric | EVP Research | Sell | 53 | $73.62 | $3.9K | 256 −17.2% of holding | |
| Birchler Brian | EVP, Corp and Development Ops | Sell 10b5-1 | 12,425 | $72.23 | $897.4K | 56,826 −17.9% of holding | |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell 10b5-1 | 6,000 | $72.94 | $437.7K | 15,937 −27.4% of holding | |
| PARSHALL B LYNNE | Director | Sell 10b5-1 | 5,000 | $71.74 | $358.7K | 61,344 −7.5% of holding | |
| Birchler Brian | EVP, Corp and Development Ops | Sell 10b5-1 | 11,475 | $72.03 | $826.6K | 56,826 −16.8% of holding | |
| O'NEIL PATRICK R. 2 fills | EVP CLO & General Counsel | Sell 10b5-1 | 13,441 | $69.74 | $937.3K | 57,130 −19% of holding | |
| Swayze Eric | EVP Research | Sell 10b5-1 | 6,849 | $69.02 | $472.7K | 30,453 −18.4% of holding | |
| Baroldi Joseph | EVP, Chief Business Officer | Sell 10b5-1 | 1,625 | $69.37 | $112.7K | 30,301 −5.1% of holding | |
| Monia Brett P | Chief Executive Officer | Sell 10b5-1 | 437 | $69.26 | $30.3K | 179,572 −0.2% of holding | |
| O'NEIL PATRICK R. 2 fills | EVP CLO & General Counsel | Sell 10b5-1 | 64,664 | $67.69 | $4.4M | 57,130 −53.1% of holding | |
| Baroldi Joseph | EVP, Chief Business Officer | Sell 10b5-1 | 15,000 | $68.01 | $1.0M | 31,926 −32% of holding | |
| Swayze Eric | EVP Research | Sell 10b5-1 | 12,972 | $66.23 | $859.1K | 37,302 −25.8% of holding | |
| WENDER JOSEPH H | Director | Sell 10b5-1 | 16,800 | $65.50 | $1.1M | 92,035 −15.4% of holding | |
| Swayze Eric | EVP Research | Sell 10b5-1 | 14,142 | $66.09 | $934.7K | 37,302 −27.5% of holding | |
| Geary Richard S | EVP, Chief Development Officer | Sell 10b5-1 | 57,900 | $65.24 | $3.8M | 79,657 −42.1% of holding | |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell 10b5-1 | 49,800 | $65.26 | $3.2M | 110,500 −31.1% of holding | |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell 10b5-1 | 14,827 | $64.68 | $959.0K | 57,130 −20.6% of holding | |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell 10b5-1 | 10,473 | $64.54 | $675.9K | 57,130 −15.5% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.